Sana Biotechnology Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M). The key difference: Sana Biotechnology Inc is far larger — about 2.7× Virgin Galactic Holdings, Inc.'s market cap. Which is the better fit depends on your goals.
| SANA | SPCE | |
|---|---|---|
Market Cap | $873.84M | $329.06M |
Sector | Health | Industrials |
52-Week High | $5.92 | $7.52 |
52-Week Low | $2.68 | $2.17 |
Enterprise Value | $848.03M | $428.90M |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →